EP2156320A4 - Techniques for purposing a new compound and for repurposing a drug - Google Patents

Techniques for purposing a new compound and for repurposing a drug

Info

Publication number
EP2156320A4
EP2156320A4 EP08828648A EP08828648A EP2156320A4 EP 2156320 A4 EP2156320 A4 EP 2156320A4 EP 08828648 A EP08828648 A EP 08828648A EP 08828648 A EP08828648 A EP 08828648A EP 2156320 A4 EP2156320 A4 EP 2156320A4
Authority
EP
European Patent Office
Prior art keywords
purposing
repurposing
drug
techniques
new compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08828648A
Other languages
German (de)
French (fr)
Other versions
EP2156320A2 (en
Inventor
Tali Eilam Zoref
Zvia Agur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Optimata Ltd
Original Assignee
Optimata Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Optimata Ltd filed Critical Optimata Ltd
Publication of EP2156320A2 publication Critical patent/EP2156320A2/en
Publication of EP2156320A4 publication Critical patent/EP2156320A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
EP08828648A 2007-05-18 2008-05-19 Techniques for purposing a new compound and for repurposing a drug Withdrawn EP2156320A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92453307P 2007-05-18 2007-05-18
PCT/IB2008/003162 WO2009027843A2 (en) 2007-05-18 2008-05-19 Techniques for purposing a new compound and for repurposing a drug

Publications (2)

Publication Number Publication Date
EP2156320A2 EP2156320A2 (en) 2010-02-24
EP2156320A4 true EP2156320A4 (en) 2010-12-15

Family

ID=40387949

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08828648A Withdrawn EP2156320A4 (en) 2007-05-18 2008-05-19 Techniques for purposing a new compound and for repurposing a drug

Country Status (2)

Country Link
EP (1) EP2156320A4 (en)
WO (1) WO2009027843A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11164657B2 (en) 2017-11-30 2021-11-02 International Business Machines Corporation Accelerated pharmaceutical repurposing by finding anticorrelations and by text mining
AU2021313137A1 (en) * 2020-07-19 2023-02-23 Inderpreet JALLI A system and method for developing an alternative drug therapy using characteristics of an existing drug therapy to produce a similar pathway behavior

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020038310A1 (en) * 2000-07-17 2002-03-28 Reitberg Donald P. Single-patient drug trials used with accumulated database: genomic markers
US7135286B2 (en) * 2002-03-26 2006-11-14 Perlegen Sciences, Inc. Pharmaceutical and diagnostic business systems and methods
WO2004025393A2 (en) * 2002-09-16 2004-03-25 Optimata, Ltd. An interactive technique for optimizing drug development from the pre-clinical phases through phase-iv

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TARTAGLIA LOUIS A.: "Complementary new approaches enable repositioning of failed drug candidates.", EXPERT OPINION ON INVESTIGATIONAL DRUGS NOV 2006 LNKD- PUBMED:17040191, vol. 15, no. 11, November 2006 (2006-11-01), pages 1295 - 1298, XP002606991, ISSN: 1744-7658 *

Also Published As

Publication number Publication date
WO2009027843A2 (en) 2009-03-05
WO2009027843A3 (en) 2009-12-30
EP2156320A2 (en) 2010-02-24

Similar Documents

Publication Publication Date Title
GB0709031D0 (en) Pharmaceutical compounds
IL201366A0 (en) Pharmaceutical compounds
GB0721095D0 (en) Pharmaceutical compounds
HK1127356A1 (en) Pharmaceutical compounds
GB0608820D0 (en) Pharmaceutical compounds
GB0707087D0 (en) Pharmaceutical compounds
ZA200809479B (en) New pharmaceutical compounds
GB0725214D0 (en) Pharmaceutical compounds
GB0704932D0 (en) Pharmaceutical compounds
GB0721669D0 (en) Pharmaceutical compounds
GB0712389D0 (en) A Pharmaceutical composition
GB0719248D0 (en) Compounds and methods for pharmaceutical use
EP2152726A4 (en) Analgesic compounds
GB0718045D0 (en) Pharmaceutical compound
GB0608184D0 (en) Pharmaceutical compounds
GB0608176D0 (en) Pharmaceutical Compounds
EP2156320A4 (en) Techniques for purposing a new compound and for repurposing a drug
GB0608264D0 (en) Pharmaceutical compounds
GB0625682D0 (en) Pharmaceutical compounds
GB0622892D0 (en) Pharmaceutical compounds
GB0608175D0 (en) Pharmaceutical Compounds
GB0707611D0 (en) Pharmaceutical compounds
GB0715676D0 (en) Pharmaceutical compounds
GB0715675D0 (en) Pharmaceutical compounds
GB0707088D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20091026

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: G06F 19/00 20060101AFI20101029BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20101116

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110215